Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 6
2003 10
2004 10
2005 14
2006 12
2007 6
2008 8
2009 8
2010 6
2011 11
2012 6
2013 6
2014 1
2015 1
2016 2
2017 4
2018 5
2019 7
2020 14
2021 14
2022 14
Text availability
Article attribute
Article type
Publication date

Search Results

151 results
Results by year
Filters applied: . Clear all
Page 1
Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial.
Gazzard G, Konstantakopoulou E, Garway-Heath D, Garg A, Vickerstaff V, Hunter R, Ambler G, Bunce C, Wormald R, Nathwani N, Barton K, Rubin G, Buszewicz M; LiGHT Trial Study Group. Gazzard G, et al. Lancet. 2019 Apr 13;393(10180):1505-1516. doi: 10.1016/S0140-6736(18)32213-X. Epub 2019 Mar 9. Lancet. 2019. PMID: 30862377 Free PMC article. Clinical Trial.
Minimally Invasive Glaucoma Surgical Techniques for Open-Angle Glaucoma: An Overview of Cochrane Systematic Reviews and Network Meta-analysis.
Bicket AK, Le JT, Azuara-Blanco A, Gazzard G, Wormald R, Bunce C, Hu K, Jayaram H, King A, Otárola F, Nikita E, Shah A, Stead R, Tóth M, Li T. Bicket AK, et al. Among authors: gazzard g. JAMA Ophthalmol. 2021 Sep 1;139(9):983-989. doi: 10.1001/jamaophthalmol.2021.2351. JAMA Ophthalmol. 2021. PMID: 34264292 Free PMC article. Review.
Efficacy of Repeat Selective Laser Trabeculoplasty in Medication-Naive Open-Angle Glaucoma and Ocular Hypertension during the LiGHT Trial.
Garg A, Vickerstaff V, Nathwani N, Garway-Heath D, Konstantakopoulou E, Ambler G, Bunce C, Wormald R, Barton K, Gazzard G; Laser in Glaucoma and Ocular Hypertension Trial Study Group. Garg A, et al. Among authors: gazzard g. Ophthalmology. 2020 Apr;127(4):467-476. doi: 10.1016/j.ophtha.2019.10.023. Epub 2019 Oct 30. Ophthalmology. 2020. PMID: 32005561 Free article. Clinical Trial.
June consultation #6.
Gazzard G. Gazzard G. J Cataract Refract Surg. 2020 Jun;46(6):925-926. doi: 10.1097/01.j.jcrs.0000681836.35111.ea. J Cataract Refract Surg. 2020. PMID: 32541415 No abstract available.
Laser in Glaucoma and Ocular Hypertension Trial (LIGHT) in China - A Randomized Controlled Trial: Design and Baseline Characteristics.
Yang Y, Jiang Y, Huang S, Zhang X, Nathwani N, Lin M, Liu X, Zhang X, Fan Y, Xu J, Gazzard G, Yu M; Light China Trial Study Group. Yang Y, et al. Among authors: gazzard g. Am J Ophthalmol. 2021 Oct;230:143-150. doi: 10.1016/j.ajo.2021.04.020. Epub 2021 May 2. Am J Ophthalmol. 2021. PMID: 33951448 Free article. Clinical Trial.
151 results